A phase 2 open trial of pentoxifylline for the treatment of leprosy reactions

Int J Lepr Other Mycobact Dis. 2002 Mar;70(1):38-43.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Erythema Nodosum / drug therapy*
  • Erythema Nodosum / immunology
  • Female
  • Humans
  • Leprosy, Borderline / drug therapy*
  • Leprosy, Borderline / immunology
  • Leprosy, Lepromatous / drug therapy*
  • Leprosy, Lepromatous / immunology
  • Leprosy, Tuberculoid / drug therapy*
  • Leprosy, Tuberculoid / immunology
  • Male
  • Middle Aged
  • Pentoxifylline / administration & dosage
  • Pentoxifylline / therapeutic use*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Tumor Necrosis Factor-alpha
  • Pentoxifylline